These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 27034792)

  • 41. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
    Oettle H; Post S; Neuhaus P; Gellert K; Langrehr J; Ridwelski K; Schramm H; Fahlke J; Zuelke C; Burkart C; Gutberlet K; Kettner E; Schmalenberg H; Weigang-Koehler K; Bechstein WO; Niedergethmann M; Schmidt-Wolf I; Roll L; Doerken B; Riess H
    JAMA; 2007 Jan; 297(3):267-77. PubMed ID: 17227978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.
    Doi R; Kami K; Ito D; Fujimoto K; Kawaguchi Y; Wada M; Kogire M; Hosotani R; Imamura M; Uemoto S
    World J Surg; 2007 Jan; 31(1):147-54. PubMed ID: 17171496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Periportal lymphadenopathy in patients without identifiable pancreatobiliary or hepatic malignancy.
    Krishna NB; Gardner L; Collins BT; Agarwal B
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1373-7. PubMed ID: 17059897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database.
    Schwarz RE; Smith DD
    Ann Surg Oncol; 2006 Sep; 13(9):1189-200. PubMed ID: 16955385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
    Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
    Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
    Stocken DD; Büchler MW; Dervenis C; Bassi C; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Neoptolemos JP;
    Br J Cancer; 2005 Apr; 92(8):1372-81. PubMed ID: 15812554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
    Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
    N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does extended lymphadenectomy improve survival of pancreatic cancer patients?
    Popiela T; Kedra B; Sierzega M
    Acta Chir Belg; 2002 Apr; 102(2):78-82. PubMed ID: 12051095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
    Neoptolemos JP; Dunn JA; Stocken DD; Almond J; Link K; Beger H; Bassi C; Falconi M; Pederzoli P; Dervenis C; Fernandez-Cruz L; Lacaine F; Pap A; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Lancet; 2001 Nov; 358(9293):1576-85. PubMed ID: 11716884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
    J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.
    Meyer W; Jurowich C; Reichel M; Steinhäuser B; Wünsch PH; Gebhardt C
    Surg Today; 2000; 30(7):582-7. PubMed ID: 10930222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
    Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
    Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.
    Pedrazzoli S; DiCarlo V; Dionigi R; Mosca F; Pederzoli P; Pasquali C; Klöppel G; Dhaene K; Michelassi F
    Ann Surg; 1998 Oct; 228(4):508-17. PubMed ID: 9790340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pathologist and the residual tumor (R) classification.
    Hermanek P; Wittekind C
    Pathol Res Pract; 1994 Feb; 190(2):115-23. PubMed ID: 8058567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
    Yeo CJ; Cameron JL; Lillemoe KD; Sitzmann JV; Hruban RH; Goodman SN; Dooley WC; Coleman J; Pitt HA
    Ann Surg; 1995 Jun; 221(6):721-31; discussion 731-3. PubMed ID: 7794076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.
    Kalser MH; Ellenberg SS
    Arch Surg; 1985 Aug; 120(8):899-903. PubMed ID: 4015380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.
    Osipov A; Naziri J; Hendifar A; Dhall D; Rutgers JK; Chopra S; Li Q; Tighiouart M; Annamalai A; Nissen NN; Tuli R
    J Gastrointest Oncol; 2016 Apr; 7(2):239-47. PubMed ID: 27034792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition.
    Xu J; Zhu J; Wei Q
    J Cancer; 2019; 10(2):458-466. PubMed ID: 30719140
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.